Thank you for the great discussions at #NANS25! Daily remote monitoring unlocks exciting opportunities with SCS data, and we’re eager to further explore these applications. #BIOTRONIKNeuro #SpinalCordStimulation #HealthcareInnovation

We are excited to announce the completion of expanded enrollment in BENEFIT-03, a long-term safety and efficacy study of the Prospera™ SCS System ongoing in Australia.  ow.ly/tZg850USKuH #BIOTRONIKNeuro #ClinicalEvidence

Help inform your SCS treatment decisions with BIOTRONIK Neuro’s new Patient Progress Report. Prospera® delivers real-time*, objective SCS data designed to make follow-up more efficient. #BIOTRONIKNeuro #SpinalCordStimulation

BioVantage™ is a first-of-its-kind service option that complements Prospera™ daily remote monitoring with a monthly review of the patient’s individualized care plan. #RemoteMonitoring #SpinalCordStimulation

How many patients use their SCS as prescribed? Track therapy adherence with BIOTRONIK Neuro’s new Patient Progress Report. Log on to the Provider Portal to get started: ow.ly/LJJy50V7Rrm #BIOTRONIKNeuro #SpinalCordStimulation #RemoteMonitoring

Prospera™ delivers real-time* patient data that can help maintain treatment plan adherence, patient engagement, and optimal SCS therapy. Log on to get started: ow.ly/BzuL50V7RVe #BIOTRONIKNeuro #SpinalCordStimulation #RemoteMonitoring

Don’t miss Healio’s Q&A featuring BIOTRONIK Neuro President Todd Langevin and highlights from BENEFIT-03, the first long-term study of SCS with daily remote monitoring. ow.ly/f61150VipX2

A new study published by the Journal of Pain Research highlights the comparative interactions of RESONANCE™ versus other therapy types in the dorsal horn: ow.ly/Zrt650Vjv18 #BIOTRONIKNeuro #ClinicalEvidence

BIOTRONIK Neuro President Todd Langevin recently spoke with DeviceTalks about SCS and the benefits of daily remote monitoring. Don’t miss the discussion: ow.ly/7J1H50VjvC8

Stop by and see us at Oregon Health & Science University’s Stereotactic and Functional Neurosurgery Course this week in Portland, OR. Learn how #BIOTRONIKNeuro uses remote monitoring to facilitate faster issue identification and management to help keep SCS therapy optimized.

Interim 24-month results from BENEFIT-03, an ongoing, long-term safety and efficacy study in Australia, highlight improved function for Prospera™ SCS patients. #BIOTRONKNeuro #ClinicalEvidence Adverse events may occur; see important safety information: ow.ly/zz7R50Vrwxr

The Prospera™ SCS System transmits device data daily, allowing our Embrace One™ Care Team to intervene when patients need help. #BIOTRONIKNeuro #RemoteMonitoring

Interim 24-month results from BENEFIT-03, a long-term safety and efficacy study (ongoing in Australia) show sleep improvement for patients using the Prospera™ SCS System. Adverse events may occur; see important safety information: ow.ly/ZrNb50Vw5nX

Two years ago, #BIOTRONIKNeuro took an important step and introduced the Prospera® Spinal Cord Stimulation System. We’re looking forward to continued success as we further innovate to optimize SCS. #EmbraceLifeAgain

This #EarthDay and every day #BIOTRONIKNeuro is proud to help shape a more environmentally sustainable future for our employees, customers and patients. #EmbraceLifeAgain

The Prospera® SCS System with Embrace One™ brings together a deep legacy of excellence, robust clinical evidence, and first-of-its-kind connectedness to elevate and optimize the SCS experience. Learn more: ow.ly/fWog50VEJ6o

Interim 24-month results from BENEFIT-03, an ongoing safety and efficacy study of the Prospera® SCS System in Australia, demonstrate long-term durability of therapeutic response. #BIOTRONIKNeuro #EmbraceLifeAgain

Chronic pain can affect patients not just physically, but mentally as well. Let’s raise mental health awareness to reduce the stigma so many experience. #MentalHealthMonth

Don’t miss this upcoming discussion on remote monitoring in SCS! ⬇️

Thank you to those who have served and sacrificed for our freedom. #MemorialDay